Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02699697 · ClinicalTrials.gov registry record · NA

Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis

A NA study of Pain and Malignant Neoplasm, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
102
Enrollment target
1
Study location

NCT02699697: Completed NA study of Pain and Malignant Neoplasm, sponsored by Wake Forest University Health Sciences.

NCT02699697 is a NA study of Pain and Malignant Neoplasm that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 102 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02699697, a NA study of Pain and Malignant Neoplasm, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
102 participants
Enrollment target
1
Study location

Study Summary

This randomized phase II trial studies how well palliative radiation therapy works in reducing pain in patients with cancer that has spread from the original (primary) tumor to the bone (bone metastasis). Palliative radiation therapy using external beam radiation therapy may help patients with bone metastasis to relieve symptoms and reduce pain caused by cancer.

Primary Outcome

The primary analysis will use a one-sided Z-test for proportions to test the null hypothesis.

Interventions

  • OTHER Quality-of-Life Assessment
  • RADIATION External Beam Radiation Therapy
  • OTHER Questionnaire Administration
  • RADIATION Palliative Radiation Therapy

Study Locations (1)

North Carolina

  • Comprehensive Cancer Center of Wake Forest University - Winston-Salem

Trial Details

FieldValue
Enrollment Target 102 participants
Start Date 2016-05
Est. Completion 2025-03-20
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT02699697 record still lists

NCT02699697 is an interventional study that assigns participants to a tested intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (66% lower).

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.

NCT02699697 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02699697 about?

NCT02699697 is a clinical study titled "Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis". This randomized phase II trial studies how well palliative radiation therapy works in reducing pain in patients with cancer that has spread from the original (primary) tumor to the bone (bone metastasis). Palliative radiation therapy using external beam radiation therapy may help patients with bone ...

What is the current status of trial NCT02699697?

This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2016-05. Estimated completion is 2025-03-20.

What conditions does trial NCT02699697 study?

This clinical trial studies the following conditions: Pain, Malignant Neoplasm, Metastatic Malignant Neoplasm in the Bone.

What interventions are being tested in trial NCT02699697?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), External Beam Radiation Therapy (RADIATION), Questionnaire Administration (OTHER), Palliative Radiation Therapy (RADIATION).

Who is sponsoring clinical trial NCT02699697?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02699697 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02699697's enrollment target sits among peer trials

102 160th of 374 higher than 212 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03704662 · 102 participants · NA

    Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma

  • NCT04174742 · 102 participants

    Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

  • NCT04275362 · 102 participants

    Gait Analysis of a Lateral-Pivot Design Total Knee Replacement

  • NCT04541082 · 102 participants · Phase 1

    Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02699697, the US trial registry maintained by the National Library of Medicine. NCT02699697 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.